Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcineurin B homologous protein 1 (CHP1) is a ubiquitously expressed, calcium-binding EF-hand protein that functions primarily as an obligate regulatory cofactor of sodium/hydrogen exchangers, especially NHE1. It is structurally related to calcineurin B and calmodulin and plays important roles in Na+/H+ exchange, membrane trafficking, vesicle targeting and fusion, and cellular pH regulation. CHP1 also participates in the inhibition of the calcineurin/NFAT pathway and gene transcription regulation, and influences processes such as axon maintenance and neurodevelopment. Disruption of CHP1 function may lead to pH dysregulation and neurological disease, reflecting its critical involvement in ion homeostasis and membrane protein trafficking[1][2][3][4].
Inhibition of sodium/proton exchange (e.g., cariporide blocks NHE1 activity by preventing conformational change in the NHE1-CHP1 complex)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcineurin B homologous protein 1 (CHP1).